illuminate: durvalumab, tremelimumab, and chemotherapy in egfr mutant nsclc | dr. ankur punia| crsf
Published 4 months ago • 11 plays • Length 5:01Download video MP4
Download video MP3
Similar videos
-
1:18
a study of chemotherapy with durvalumab and tremelimumab in nsclc
-
2:03
tremelimumab and durvalumab therapy in lung cancer
-
44:01
webinar: combination of durvalumab, bevacizumab, tremelimumab & transarterial chemoembolization
-
3:25
new technology can help doctors diagnosis lung cancer earlier
-
2:56
durvalumab after chemoradiotherapy improves overall survival in lung cancer patients
-
2:52
पूरे शरीर में कैंसर फैल गया था, आयर्वेद से मिला आराम | acharya manish ji | sadhna tv
-
26:13
immunotherapies in lung cancer | 2022 evolution conference
-
1:19
test your lung capacity | test your lung capacity zydus | check your lung capacity
-
3:30
immunotherapy treatments for non-small cell lung cancer (nsclc)
-
1:42
dr. feldman on the future of durvalumab and tremilimumab in nsclc
-
6:27
how early detection of lung cancer can help save you life
-
4:15
cure for lung cancer? study finds new pill cuts risk of death | vantage with palki sharma
-
0:24
dr. david midthun discusses what the prototype lung cancer blood test means for the future
-
1:21
an expanding role for targeted therapies and testing in lung cancer: best of lung 2023
-
1:02
an expert looks to the future of metastatic kidney cancer treatment
-
1:59
lung cancer: what are risks and symptoms?
-
0:36
advancements in lung cancer research
-
1:00:41
basic and translational science in the time of the immune revolution in cancer
-
7:47
combination tremelimumab and durvalumab in hcc
-
1:10
🔰 diagnosis of lung cancer means end of life | 🔰 end-of-life lung cancer signs & symptoms
-
1:37
lung cancer treatment in india | best explained by dr. ishu gupta
-
2:11
new technology detecting early stages of lung cancer